Sandeep Kulkarni is an Investment Analyst in the Biotech Group at QVT Financial. He covers public and private investment opportunities spanning all therapeutic areas, with a focus on oncology, hematology, and endocrinology. Prior to joining QVT in 2013, Dr Kulkarni was a Project Leader with the Boston Consulting Group, working exclusively within the life sciences. He has conducted research at the Institute of Health Metrics and Evaluation in Seattle, where his work used econometrics to model trends in global and domestic disease burden. Dr Kulkarni received his M.D. from the University of California, San Francisco, and his A.B. from Harvard College.